Status: current, Defined. Date: 31-May 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3935901000168113 | Xelocitabine (capecitabine 500 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3935911000168111 | Xelocitabine 500 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xelocitabine 500 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Xelocitabine 500 mg tablet | Is a | capecitabine 500 mg tablet | true | Inferred relationship | Some | ||
| Xelocitabine 500 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Xelocitabine 500 mg tablet | Is a | Xelocitabine | true | Inferred relationship | Some | ||
| Xelocitabine 500 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Xelocitabine 500 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 963878613 | |
| Xelocitabine 500 mg tablet | has Australian BoSS | capecitabine | true | Inferred relationship | Some | 963878612 | |
| Xelocitabine 500 mg tablet | has intended active ingredient | capecitabine | true | Inferred relationship | Some | 963878612 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xelocitabine 500 mg tablet, 120, blister pack | has TPUU | True | Xelocitabine 500 mg tablet | Inferred relationship | Some | 1 |
| Xelocitabine 500 mg tablet, 120 | has TPUU | True | Xelocitabine 500 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR